Cardiovascular Systems Total Assets 2006-2019 | CSII

Cardiovascular Systems total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Cardiovascular Systems Annual Total Assets
(Millions of US $)
2019 $219
2018 $203
2017 $194
2016 $142
2015 $171
2014 $182
2013 $97
2012 $63
2011 $47
2010 $43
2009 $72
2008 $47
2008 $42
2007 $95
2007 $0
2006 $136
2006 $12
2005 $64
2005 $0
Cardiovascular Systems Quarterly Total Assets
(Millions of US $)
Q4 2019 $219
Q3 2019 $211
Q2 2018 $207
Q1 2018 $200
Q4 2018 $203
Q3 2018 $195
Q2 2017 $190
Q1 2017 $190
Q4 2017 $194
Q3 2017 $187
Q2 2016 $159
Q1 2016 $138
Q4 2016 $142
Q3 2016 $145
Q2 2015 $151
Q1 2015 $162
Q4 2015 $171
Q3 2015 $179
Q2 2014 $181
Q1 2014 $182
Q4 2014 $182
Q3 2014 $185
Q2 2013 $181
Q1 2013 $95
Q4 2013 $97
Q3 2013 $99
Q2 2012 $57
Q1 2012 $60
Q4 2012 $63
Q3 2012 $50
Q2 2011 $52
Q1 2011 $48
Q4 2011 $47
Q3 2011 $44
Q2 2010 $45
Q1 2010 $42
Q4 2010 $43
Q3 2010 $62
Q2 2009 $64
Q1 2009 $70
Q4 2009 $72
Q3 2009 $76
Q2 2008 $0
Q1 2008 $52
Q4 2008 $0
Q3 2008 $81
Q2 2007 $0
Q1 2007 $107
Q4 2007 $117
Q3 2007 $126
Q2 2006 $0
Q1 2006 $143
Q4 2006 $106
Q3 2006 $0
Q2 2005 $64
Q1 2005 $0
Q4 2005 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.794B $0.248B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.939B 28.00
Medtronic (MDT) Ireland $147.141B 20.65
Stryker (SYK) United States $81.622B 28.23
Boston Scientific (BSX) United States $58.240B 28.25
Baxter (BAX) United States $44.383B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.496B 18.24
Lonza Group Ag (LZAGY) Switzerland $25.271B 0.00
Coloplast (CLPBY) Denmark $24.948B 39.83
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $20.407B 0.00
ResMed (RMD) United States $18.992B 36.22
Sunny Optical Technology (SNPTF) China $16.672B 0.00
Bio-Rad Laboratories (BIO) United States $9.967B 53.43
Canopy Growth (CGC) Canada $9.552B 0.00
Insulet (PODD) United States $8.633B 511.57
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.024B 20.94
Haemonetics (HAE) United States $6.359B 47.99
Aurora Cannabis (ACB) Canada $6.071B 0.00
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
GW Pharmaceuticals (GWPH) United Kingdom $4.356B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.116B 68.33
NuVasive (NUVA) United States $3.380B 26.95
ICU Medical (ICUI) United States $3.364B 21.82
Hutchison China MediTech (HCM) China $2.903B 0.00
Quidel (QDEL) United States $2.783B 27.64
National Vision Holdings (EYE) United States $2.407B 51.95
Agios Pharmaceuticals (AGIO) United States $2.217B 0.00
Aphria (APHA) $1.687B 0.00
VAREX IMAGING (VREX) United States $1.129B 26.01
AtriCure (ATRC) United States $0.989B 0.00
Lantheus Holdings (LNTH) United States $0.956B 25.12
Omeros (OMER) United States $0.915B 0.00
Phibro Animal Health (PAHC) United States $0.866B 14.08
Eagle Pharmaceuticals (EGRX) United States $0.787B 20.07
NanoString Technologies (NSTG) United States $0.774B 0.00
PetIQ (PETQ) United States $0.751B 17.74
Cerus (CERS) United States $0.747B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 41.80
Quanterix (QTRX) United States $0.654B 0.00
MacroGenics (MGNX) United States $0.640B 0.00
Surmodics (SRDX) United States $0.632B 120.08
TG Therapeutics (TGTX) United States $0.614B 0.00
OraSure Technologies (OSUR) United States $0.468B 21.69
Meridian Bioscience (VIVO) United States $0.422B 13.16
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.409B 0.00
Owens & Minor (OMI) United States $0.394B 11.81
BioLife Solutions (BLFS) United States $0.385B 126.69
Utah Medical Products (UTMD) United States $0.369B 27.00
United Health Products (UEEC) United States $0.325B 0.00
Zynex (ZYXI) United States $0.292B 31.03
Bovie Medical (APYX) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.197B 0.00
Cytosorbents (CTSO) United States $0.177B 0.00
Vapotherm (VAPO) United States $0.159B 0.00
Fonar (FONR) United States $0.157B 11.17
Chimerix (CMRX) United States $0.135B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
InfuSystems Holdings (INFU) United States $0.106B 0.00
United-Guardian (UG) United States $0.088B 20.72
MRI Interventions (MRIC) United States $0.065B 0.00
Nephros (NEPH) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
Senestech (SNES) United States $0.025B 0.00
Myomo (MYO) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00